VSM Wealth Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VSM Wealth Advisory's BIIB Position: Q2 2026 in Review
VSM Wealth Advisory held its Biogen (BIIB) position steady in Q2 2026 at 92 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #300.
VSM Wealth Advisory first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- VSM Wealth Advisory held 92 shares of Biogen worth $19.9K as of Q2 2026.
- VSM Wealth Advisory left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #300 holding.
- VSM Wealth Advisory first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.